The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of…
The United States Congress has finalized and passed a comprehensive funding bill for the Department of Health and Human Services…
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a comprehensive educational initiative…
In a landmark development for the treatment of type 2 diabetes and metabolic health, Eli Lilly and Company has announced…
The study provides a detailed roadmap of how semaglutide interacts with the tumor microenvironment (TME), specifically targeting immune cells known…
In observance of American Heart Month this February, the medical community is intensifying its focus on the intersection of metabolic…
As the pharmaceutical landscape undergoes a seismic shift driven by the proliferation of anti-obesity and glucose-lowering medications, the medical community…
In a strategic move to address the growing financial and professional challenges facing the global scientific community, the Endocrine Society…
The field of neuroendocrinology is currently undergoing a transformative shift as researchers move beyond traditional observational studies toward sophisticated molecular…
The pharmaceutical landscape is currently witnessing a paradigm shift as glucagon-like peptide-1 receptor agonists (GLP-1RAs), once specialized tools for glycemic…
Amara Maple